Tony Jourdan

2.5k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Tony Jourdan is a scholar working on Pharmacology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tony Jourdan has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 13 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tony Jourdan's work include Cannabis and Cannabinoid Research (24 papers), Pancreatic function and diabetes (13 papers) and Diet, Metabolism, and Disease (12 papers). Tony Jourdan is often cited by papers focused on Cannabis and Cannabinoid Research (24 papers), Pancreatic function and diabetes (13 papers) and Diet, Metabolism, and Disease (12 papers). Tony Jourdan collaborates with scholars based in United States, France and Hungary. Tony Jourdan's co-authors include George Kunos, Grzegorz Godlewski, Reşat Çınar, Joseph Tam, Gergő Szanda, Bani Mukhopadhyay, Jie Liu, Pascal Degrace, Laurent Demizieux and Bruno Vergès and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Tony Jourdan

35 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

2013 329 citations Tony Jourdan, Grzegorz Godlewski et al. profile →

Peers

Countries citing papers authored by Tony Jourdan

Since Specialization

Citations

This map shows the geographic impact of Tony Jourdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Jourdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Jourdan more than expected).

Fields of papers citing papers by Tony Jourdan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Jourdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Jourdan. The network helps show where Tony Jourdan may publish in the future.

Co-authorship network of co-authors of Tony Jourdan

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Jourdan. A scholar is included among the top collaborators of Tony Jourdan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Jourdan. Tony Jourdan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis 2025 ·JCI Insight ·Abhishek Basu, Muhammad Arif, (unknown), (unknown), (unknown), (unknown), Ricardo Pineda, John Sembrat, (unknown), Szabolcs Dvorácskó, Nathan J. Coffey, Joshua K. Park, (unknown), Grzegorz Godlewski, Tony Jourdan, Judith Harvey‐White, Mélanie Königshoff, Malliga R. Iyer, Reşat Çınar	0
2	Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders 2025 ·Journal of Medicinal Chemistry ·(unknown), Szabolcs Dvorácskó, (unknown), (unknown), (unknown), Luca Maccioni, Grzegorz Godlewski, Tony Jourdan, Sergio A. Hassan, Reşat Çınar, Malliga R. Iyer	0
3	A Simplified and Robust Model for the Study of Diabetic Nephropathy: Streptozotocin-Induced Diabetic Mice Fed a High-Protein Diet 2025 ·International Journal of Molecular Sciences ·(unknown), Regina María Barbosa, Marie‐Anne Loriot, Julia Leemput, Élisabeth Dubus, Sébastien Causse, Laurent Demizieux, Patricia Passilly‐Degrace, Pascal Degrace, Bruno Vergès, Tony Jourdan	0
4	Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders 2025 ·Metabolism ·(unknown), Szabolcs Dvorácskó, (unknown), Biswajit Kundu, (unknown), Henry L. Puhl, Jie Liu, Grzegorz Godlewski, Sergio A. Hassan, Tony Jourdan, Reşat Çınar, Malliga R. Iyer	1
5	A human laboratory study on the link between alcohol administration and circulating fibroblast growth factor 21 (FGF21) in individuals with alcohol use disorder 2023 ·Drug and Alcohol Dependence ·Mehdi Farokhnia, (unknown), Tony Jourdan, Grzegorz Godlewski, Lisa A. Farinelli, George Kunos, Lorenzo Leggio	7
6	Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Patricia Passilly‐Degrace, (unknown), (unknown), Julia Leemput, (unknown), Laurent Demizieux, Bruno Vergès, Pascal Degrace, Glenn Crater, Tony Jourdan	11
7	Cannabinoid receptor type 1 (CB1R) inhibits hypothalamic leptin signaling via β-arrestin1 in complex with TC-PTP and STAT3 2023 ·iScience ·Gergő Szanda, Tony Jourdan, Éva Wisniewski, Reşat Çınar, Grzegorz Godlewski, (unknown), (unknown), (unknown), Bence Szalai, András Dávid Tóth, (unknown), László Hunyady, Asuka Inoue, (unknown), András Spät, Joseph Tam, George Kunos	3
8	Inhibition of mitochondrial fatty acid β-oxidation activates mTORC1 pathway and protein synthesis via Gcn5-dependent acetylation of Raptor in zebrafish 2023 ·Journal of Biological Chemistry ·Wenhao Zhou, Yuan Luo, Ruixin Li, Pascal Degrace, Tony Jourdan, Fang Qiao, Liqiao Chen, Mei‐Ling Zhang, Zhen‐Yu Du	11
9	Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist 2022 ·International Journal of Molecular Sciences ·(unknown), Laurent Demizieux, (unknown), (unknown), Julia Leemput, Christine Belloir, Jean-Paul Paı̈s de Barros, Tony Jourdan, Patricia Passilly‐Degrace, Xavier Fioramonti, Anne‐Marie Le Bon, Bruno Vergès, Jean‐Michel Robert, Pascal Degrace	7
10	Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB₁R) Antagonist 2021 ·ACS Pharmacology & Translational Science ·Ziyi Liu, Malliga R. Iyer, Grzegorz Godlewski, Tony Jourdan, Jie Liu, Nathan J. Coffey, (unknown), Henry L. Puhl, Jürgen Wess, Jaroslawna Meister, Jeih‐San Liow, Robert B. Innis, Sergio A. Hassan, Yong Sok Lee, George Kunos, Reşat Çınar	43
11	Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human 2021 ·Frontiers in Endocrinology ·(unknown), (unknown), Julia Leemput, Patricia Passilly‐Degrace, Pablo Ortega‐Deballon, Jean-Paul Paı̈s de Barros, Bruno Vergès, Tony Jourdan, Laurent Demizieux, Pascal Degrace	9
12	Targeting Peripheral CB1 Receptors Reduces Ethanol Intake via a Gut-Brain Axis 2019 ·Cell Metabolism ·Grzegorz Godlewski, Reşat Çınar, Nathan J. Coffey, Jie Liu, Tony Jourdan, Bani Mukhopadhyay, (unknown), Ziyi Liu, Douglas Osei‐Hyiaman, Malliga R. Iyer, Joshua K. Park, Roy G. Smith, Hiroshi Iwakura, George Kunos	45
13	Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis 2017 ·JCI Insight ·Reşat Çınar, Bernadette R. Gochuico, Malliga R. Iyer, Tony Jourdan, Tadafumi Yokoyama, Joshua K. Park, Nathan J. Coffey, (unknown), Gergő Szanda, Ziyi Liu, Ken Mackie, William A. Gahl, George Kunos	68
14	Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis 2016 ·JCI Insight ·Reşat Çınar, Malliga R. Iyer, Ziyi Liu, Zongxian Cao, Tony Jourdan, Katalin Erdélyi, Grzegorz Godlewski, Gergő Szanda, Jie Liu, Joshua K. Park, Bani Mukhopadhyay, Avi Z. Rosenberg, (unknown), Robin G. Lorenz, Pál Pacher, Robert B. Innis, George Kunos	63
15	Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides 2013 ·Hepatology ·Reşat Çınar, Grzegorz Godlewski, Jie Liu, Joseph Tam, Tony Jourdan, Bani Mukhopadhyay, Judith Harvey‐White, George Kunos	144
16	Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance 2012 ·Cell Metabolism ·Joseph Tam, Reşat Çınar, Jie Liu, Grzegorz Godlewski, (unknown), Tony Jourdan, Gergő Szanda, Bani Mukhopadhyay, (unknown), Jeih‐San Liow, Robert B. Innis, Kejun Cheng, Kenner C. Rice, Jeffrey R. Deschamps, Robert J. Chorvat, John F. McElroy, George Kunos	296
17	Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: Evidence from cultured explants 2011 ·Hepatology ·Tony Jourdan, Laurent Demizieux, Joseph Gresti, (unknown), (unknown), Bruno Vergès, Pascal Degrace	55
18	Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants 2010 ·Diabetes/Metabolism Research and Reviews ·(unknown), Tony Jourdan, Laurent Demizieux, Michaël Chevrot, Joseph Gresti, Bruno Vergès, Pascal Degrace	16
19	Gene expression and protein content in relation to intramuscular fat content in Muscovy and Pekin ducks 2009 ·Poultry Science ·Guillermo T. Sáez, S. Davail, (unknown), Jean-François J.-F. Hocquette, Tony Jourdan, Pascal Degrace, Élisabeth Baéza	48
20	Liver Carbohydrate and Lipid Metabolism of Insulin-Deficient Mice Is Altered by trans-10, cis-12 Conjugated Linoleic Acid , 2009 ·Journal of Nutrition ·Tony Jourdan, (unknown), Laurent Demizieux, Joseph Gresti, Bruno Vergès, Pascal Degrace	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact